Selective HDAC6 inhibition protects against blood–brain barrier dysfunction after intracerebral hemorrhage
CNS Neuroscience & Therapeutics · 2024
DOI: 10.1111/cns.14429 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Cuiying Peng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Tubulin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan province, Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University.
Abstract (Originalsprache)
Backgrounds Blood–brain barrier (BBB) disruption after intracerebral hemorrhage (ICH) significantly induces neurological impairment. Previous studies showed that HDAC6 knockdown or TubA can protect the TNF‐induced endothelial dysfunction. However, the role of HDAC6 inhibition on ICH‐induced BBB disruption remains unknown.
Methods
Hemin‐induced human brain microvascular endothelial cells (HBMECs) and collagenase‐induced rats were employed to investigated the underlying impact of the HDAC6 inhibition in BBB lesion and neuronal dysfunction after ICH.
Results
We found a significant decrease in acetylated α‐tubulin during early phase of ICH. Both 25 or 40 mg/kg of TubA could relieve neurological deficits, perihematomal cell apoptosis, and ipsilateral brain edema in ICH animal model. TubA or specific siRNA of HDAC6 inhibited apoptosis and reduced the endothelial permeability of HBMECs. HDAC6 inhibition rescued the degradation of TJ proteins and repaired TJs collapses after ICH induction. Finally, the results suggested that the protective effects on BBB after ICH induction were exerted via upregulating the acetylated α‐tubulin and reducing stress fiber formation.
Conclusions
Inhibition of HDAC6 expression showed beneficial effects against BBB disruption after experimental ICH, which suggested that HDAC6 could be a novel and promising target for ICH treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Neurology, Hunan Provincial Rehabilitation Hospital, Hunan University of Medicine, Changsha, Hunan, China.
ORCID-Profile: Cuiying Peng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan province
- Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University
Zitieren
APA
Peng, C., Wang, Y., Hu, Z., & Chen, C. (2024). Selective HDAC6 inhibition protects against blood–brain barrier dysfunction after intracerebral hemorrhage. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.14429
Vancouver
Peng C, Wang Y, Hu Z, Chen C. Selective HDAC6 inhibition protects against blood–brain barrier dysfunction after intracerebral hemorrhage. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.14429
BibTeX
@article{Peng2024,
author = {Peng, Cuiying and Wang, Yilin and Hu, Zhiping and Chen, Chunli},
title = {Selective HDAC6 inhibition protects against blood–brain barrier dysfunction after intracerebral hemorrhage},
journal = {CNS Neuroscience & Therapeutics},
year = {2024},
doi = {10.1111/cns.14429}
}
EUVIMED